Navigation Links
Advanced therapy offers cure for relapsed cancer patient

INDIANAPOLIS -- Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.

About 90 percent of testicular cancer patients respond to traditional therapy, which involves multiple courses of cisplatin, first used successfully in the treatment of this disease by Lawrence Einhorn, M.D., at Indiana University Cancer Center in the early 1980s. That course of therapy turned a disease from a mostly fatal cancer into one of the more curable forms of cancer for men, who typically are in their 20s when diagnosed with testicular cancer.

It is rare for the NEJM to carry a retrospective study from a single institution that is not a randomized study. This review looks at the outcome of 184 patients with metastatic testicular cancer. Dr. Einhorn and colleagues demonstrated that the disease is potentially curable with a high dose chemotherapy and stem cell transplant using cells harvested from the patient before the initial chemotherapy infusion.

The patients received carboplatin chemotherapy at five times the dosage administered to men receiving initial therapy. A side effect of the high dosage is a reduction of blood cells so a stem cell transplant is given to replenish the body’s immune system through a process similar to a blood transfusion. Three to four weeks later the entire process is repeated.

“The message for patients is that through research, diligence and new technologies there is hope,” said Dr. Einhorn, professor of medicine at the Indiana University Melvin and Bren Simon Cancer Center and the lead author of the study. “The bar is steadily being raised and more patients are being saved.”

“This review confirms that high-dose chemotherapy combined with a stem cell transplant can provide a cure for a group of patients with relaps ed testicular cancer,” said Rafat Abonour, M.D., associate professor of medicine in the division of hematology/oncology and associate dean for clinical research at the IU School of Medicine.

Although the number of relapsed testicular cancer patients is small, the IU Simon Cancer Center treats a majority of them. As a leader in this treatment, the researchers were able to collect the necessary data for the NEJM retrospective.

For the patients each year who are treated with this therapy, there is renewed hope. “This is new medicine and it tells patients that cures are on the horizon,” said Stephen D. Williams, M.D., director of the IU Simon Cancer Center and a co-author of the paper.   (Indiana University)


'"/>




Related medicine news :

1. Innovative device aids in advanced heart failure
2. Advanced STD programs required
3. Light therapy devotes new hope in advanced lung cancer
4. Hope For Patients With Advanced Breast Cancer
5. Race an important links to the risk of advanced colorectal cancer
6. HIV Vaccine Field Trials In Advanced Stage
7. Twin Treatment Could Be Used Increase Survival Rates In Advanced Melanoma
8. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
9. Eddie Thompson Receives Advanced Cancer Treatment
10. PSA Can Predicts The Treatment Response In Advanced Prostate Cancer
11. Rapid Aging of Arteries In People With Advanced Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2017)... ... , ... Breast Surgeon, Dr. Dennis Holmes of 90210 Surgery Medical Center will ... it fits in the treatment paradigm at Susan G. Komen San Diego’s Annual Dinner ... leading cancer and wellness experts to share the latest innovations in breast cancer research, ...
(Date:3/1/2017)... ... 2017 , ... Award-winning medical group Allied Anesthesia today announced that, as of ... averaging more than one trip per year since 1998. Char was named the Los ... the details of his charitable work. Char has been an Allied Anesthesiologist since 2000. ...
(Date:3/1/2017)... (PRWEB) , ... March 01, 2017 , ... ... pledge to help increase colorectal cancer screening rates by supporting the 80% by ... Control and Prevention (CDC) and the National Colorectal Cancer Roundtable (an organization co-founded ...
(Date:3/1/2017)... ... March 01, 2017 , ... March 2017 – All year ... people don’t want to stop training to brave the cold weather, snow or ice. ... a small incline can help protect these vulnerable joints, says orthopaedic surgeon Kevin D. ...
(Date:3/1/2017)... , ... March 01, 2017 , ... “There is Comfort ... she gave to the author in their all-too-brief time together, and the soul-healing comfort ... the Soul” is the creation of published author, Jerie A. Tau, a dog-loving medical ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... BRENTWOOD, Tenn. , March 1, 2017  Numotion, ... has announced the availability of Tek RMD ("robotic mobilization ... States . Tek RMD is a motorized standing ... are in a manual wheelchair to complete everyday activities ... board and control a Tek RMD unassisted. Numotion is ...
(Date:3/1/2017)... ... Research and Markets has announced the addition of the ... The Global Infertility Therapy Partnering Terms and Agreements ... agreements entered into by the world,s leading healthcare companies. ... deals are discovery or development stage whereby the licensee obtains a ...
(Date:3/1/2017)... MUMBAI, India and PRINCETON, ... Pharmaceutical Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, ... its subsidiaries or associate companies) today announced that ... Phase-3 clinical trials (reSURFACE 1 and 2) of ... the treatment of moderate-to-severe plaque psoriasis, will be ...
Breaking Medicine Technology: